GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 45 filers reported holding GALERA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,878 | -94.5% | 313,226 | -1.4% | 0.00% | – |
Q2 2023 | $990,752 | +97.2% | 317,549 | +61.8% | 0.00% | – |
Q1 2023 | $502,374 | +193120.8% | 196,240 | +12.2% | 0.00% | – |
Q4 2022 | $260 | -99.9% | 174,924 | +5.6% | 0.00% | – |
Q3 2022 | $288,000 | +179.6% | 165,651 | +108.7% | 0.00% | – |
Q2 2022 | $103,000 | -45.2% | 79,364 | 0.0% | 0.00% | – |
Q1 2022 | $188,000 | -45.3% | 79,364 | +5.6% | 0.00% | – |
Q4 2021 | $344,000 | -43.6% | 75,143 | -0.3% | 0.00% | – |
Q3 2021 | $610,000 | -12.9% | 75,350 | +5.7% | 0.00% | – |
Q2 2021 | $700,000 | -31.7% | 71,256 | -38.7% | 0.00% | – |
Q1 2021 | $1,025,000 | -11.9% | 116,266 | +2.2% | 0.00% | – |
Q4 2020 | $1,163,000 | +26.7% | 113,708 | +11.9% | 0.00% | – |
Q3 2020 | $918,000 | +36.6% | 101,598 | +7.9% | 0.00% | – |
Q2 2020 | $672,000 | +43.9% | 94,185 | +91.4% | 0.00% | – |
Q1 2020 | $467,000 | -52.4% | 49,217 | -34.2% | 0.00% | – |
Q4 2019 | $982,000 | – | 74,748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nan Fung Group Holdings Ltd | 613,223 | $913,702 | 0.63% |
SECTORAL ASSET MANAGEMENT INC | 1,666,666 | $2,483,332 | 0.48% |
Sofinnova Investments, Inc. | 3,083,712 | $4,594,731 | 0.27% |
Novo Holdings A/S | 2,459,021 | $3,663,941 | 0.23% |
Tekla Capital Management LLC | 898,374 | $1,338,577 | 0.05% |
Blackstone Inc. | 1,678,984 | $2,501,686 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 187,000 | $278,630 | 0.01% |
Ensign Peak Advisors, Inc | 151,777 | $226,148 | 0.00% |
TCI Wealth Advisors, Inc. | 6,162 | $9,181 | 0.00% |
Tower Research Capital LLC (TRC) | 17,819 | $27 | 0.00% |